Founded
31 Dec 1979
Address
Sanderling Ventures
400 South El Camino Real
Suite 1200
San Mateo, CA 94402
United States
Phone
Website
Industry
VCID: 30602
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Sanderling Venture Partners IV LP | ||
| Sanderling Venture V LP | ||
| Sanderling V Biomedical LP | ||
| Sanderling IV Biomedical LP |
Funding
Funding rounds
Cap Table
Current and past shareholders
| Investor | Round | |
|---|---|---|
|
Ascension Health Ventures LLC |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Torax Medical Inc |
United States | 1 Jun 2005 1 Sep 2012 |
Series D |
|
|
|
Chimerix Inc |
United States | 1 Aug 2009 1 Feb 2007 1 Feb 2011 1 Nov 2004 1 Sep 2003 |
Series F |
|
|
|
LineaGen Inc Novel biomarkers company for the development of new diagnostic tests. |
United States | 1 Aug 2010 1 Jan 2011 |
Series B Active |
|
|
|
InfraReDx Inc Medical device company focused on developing and delivering products and technologies for improved clinical decision-making. |
United States | 1 Oct 2010 | Series D |
|
|
Neomend Inc A biomedical device company, engages in the development and commercialization of surgical wound healing products |
United States | 1 Jan 2010 | Series D Active |
|
|
|
Endocyte Inc Folate-based cancer and autoimmune disease therapies |
United States | 1 Jan 2010 | Series C |
|
|
|
Gemin X Pharmaceuticals Inc |
Canada | 1 Jul 2008 | Series C |
|
|
|
Naviscan Inc |
United States | 4 May 2007 | Series C |
|
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 | Series C Active |
|
|
|
DynaTherm Medical Inc |
United States | 1 Dec 2006 | Series B |
|
|
|
Taligen Therapeutics Inc |
United States | 1 Aug 2005 | Series A |
|
|
Tenex Greenhouse Ventures LLC |
United States | 31 Dec 2001 | Fund Closing Active |
|
|
Aderis Pharmaceuticals Inc Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. |
United States | 9 Oct 2001 | Series D Initial investment. Round participant. Active |
|
|
|
CoMentis Inc |
United States | N/A |